Shuwei Wu

发表

Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

T. Yang, Sheng Tian, Jingrui Wang, 2021, European journal of medicinal chemistry.

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.

L. Luo, Xu Wang, Xiaohu Zhang, 2020, European journal of medicinal chemistry.

Synthesis and characterization of potent RIPK3 inhibitors based on a tricyclic scaffold.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2022, Future medicinal chemistry.

Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template.

L. Luo, Xiaohu Zhang, Haikuo Ma, 2020, Bioorganic chemistry.

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury

Jingrui Wang, Xiaohu Zhang, Haikuo Ma, 2020, Frontiers in Cell and Developmental Biology.

SPR-enhanced visible photoreactivity of Bi/Bi2SiO5 for salicylic acid degradation

Dongmei Bao, Hua Gao, Yuanhui Wu, 2022, Journal of Solid State Chemistry.

Molecular cloning and overexpression of the tyrosine aminotransferase (TAT) gene leads to increased rosmarinic acid yield in Perilla frutescens

F. Wang, Chen Huang, Xiaoling Lu, 2013, Plant Cell, Tissue and Organ Culture (PCTOC).

Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2022, Bioorganic chemistry.

Ring closure strategy leads to potent RIPK3 inhibitors.

Xiaohu Zhang, Haikuo Ma, S. He, 2021, European journal of medicinal chemistry.

Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.

Jingrui Wang, Xiaohu Zhang, S. He, 2022, Bioorganic & medicinal chemistry letters.

Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines

Sheng Tian, L. Luo, C. Fu, 2020, ChemMedChem.

Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis

Linghong Guo, Zhixuan Li, Yuanyuan Xu, 2023, Frontiers in Immunology.

Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2023, European journal of medicinal chemistry.

Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2023, Bioorganic chemistry.

Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease.

Xin Chen, Xiaohu Zhang, Xue-bo Sun, 2023, Biochemical pharmacology.